Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS) Protocol

To evaluate the effectiveness, feasibility, acceptability, and appropriateness of an ototoxicity screening protocol among head and neck (H&N) cancer patients followed in survivorship clinic that received cisplatin-based chemoradiation therapy (CRT).

Inclusion Criteria:

• Adult (≥ 18 years old)
• H&N cancer patients will be eligible for inclusion if they have previously undergone cisplatin-based CRT or radiotherapy, including proton therapy, intensity-modulated radiation therapy, and adaptive radiotherapy-surgery with curative intent (i.e., definitive, neoadjuvant, or adjuvant) or definitive surgery with neoadjuvant or adjuvant radiation.

Exclusion Criteria:

• Patient has been evaluated by an audiologist within the past 12 months
• Use of a hearing aid
• Received a cochlear implant
• Cannot complete simple forms in English